Journey Medical Corp Announces New Journey with the Experts Video Featuring Rachel Maiman, MD

SCOTTSDALE, Ariz. - Dec. 17, 2021 - PRLog -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical") today released a new Journey with the Experts video featuring Rachel Maiman, MD, a board-certified dermatologist with Marmur Medical in New York, New York. Dr. Maiman sits down with Journey Medical to discuss adult female acne, including what it is, why it occurs, and how those affected can seek treatment from their local dermatology practice.

According to the American Academy of Dermatology, women tend to develop adult acne more often than men. Fluctuating hormone levels, family history, stress, and the use of certain hair and skin care products are some of the reasons why adult women develop acne. To view the Journey with the Experts video featuring Dr. Maiman, please visit https://vimeo.com/651680033/055752589f.



About Journey with the Experts

Journey with the Experts is an educational initiative supported by Journey Medical Corporation, the medical dermatology company. The initiative is designed to educate the general public on common medical dermatology skin disorders and explain how these conditions can be treated at local dermatology practices.

The information, including, without limitation, topics, presentations, discussions, content, descriptions or any other material contained herein is for informational purposes only. None of the material herein is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified HCP with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking it because of something you have heard, observed, or inferred herein. Any reliance is strictly prohibited.

About Journey Medical Corporation

Journey Medical (NASDAQ:DERM) is a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company currently markets seven products that help treat and heal common skin conditions. The Journey Medical team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (NASDAQ:FBIO). For additional information about Journey Medical, visit https://journeymedicalcorp.com/.

About Rachel Maiman, MD

Dr. Maiman is a board-certified general and cosmetic dermatologist. In addition to a longstanding passion for aesthetic dermatology, her clinical expertise also encompasses complex medical and pediatric dermatology. She excels at managing conditions with variable severity, a result of excellent training in immunodermatology and the use of advanced systemic therapies. Her cosmetic expertise is also comprehensive. In addition to excelling at the use of injectables, including neuromodulators and volumizers, she is proficient in laser surgery, microneedling, platelet-rich plasma (PRP), radiofrequency, and body contouring devices. Her general dermatology interests include acne and acne scarring, melasma, rosacea, hair loss, and transgender dermatology.

Dr. Maiman graduated magna cum laude from the University of Southern California in Los Angeles. She earned her medical degree from Georgetown University School of Medicine in Washington, D.C., where she graduated magna cum laude and earned the Thomas F. Keller Award for the most outstanding academic performance in internal medicine. She completed her medicine internship at North Shore University Hospital / Long Island Jewish Medical Center, where she was prestigiously awarded Intern of the Year. A proud "double Hoya," she returned to Georgetown University to complete her dermatology residency, where she spent two years outlining and executing the resident cosmetic curriculum.

As a clinical instructor at The Mount Sinai Hospital, Dr. Maiman dedicates her time once weekly rounding on the inpatient dermatology service and teaching dermatology residents. She is an active member of the American Academy of Dermatology and the American Society for Dermatologic Surgery. In addition to lecturing on both general and cosmetic dermatology at local and national meetings, she is well-published in peer-reviewed journals and has authored several textbook chapters. For additional information about Dr. Maiman, please visit https://marmurmedical.com/about/rachel-maiman-md/.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. As used below and throughout this press release, the words "we", "us" and "our" refer to Journey Medical. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of research and development activities; uncertainties relating to preclinical and clinical testing; risks relating to the timing of starting and completing clinical trials; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as may be required by law.